PGEMX | RLBGX | PGEMX / RLBGX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 30 years | 15 years | - |
Gain YTD | 15.460 | 14.291 | 108% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 250 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.04B | 236B | 1% |
Annual Yield % from dividends | 0.70 | 2.55 | 27% |
Returns for 1 year | 26.15 | 24.80 | 105% |
Returns for 3 years | 9.08 | 15.69 | 58% |
Returns for 5 years | 31.42 | 41.00 | 77% |
Returns for 10 years | 71.39 | 56.90 | 125% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
BMCRX | 26.25 | N/A | N/A |
BlackRock Advantage Large Cap Gr R | |||
MAAWX | 10.07 | N/A | N/A |
Morgan Stanley US Focus Real Estate I | |||
VILSX | 40.23 | -0.03 | -0.07% |
Value Line Select Growth Institutional | |||
FBIOX | 21.71 | -0.09 | -0.41% |
Fidelity Select Biotechnology | |||
ETMGX | 32.49 | -0.35 | -1.07% |
Eaton Vance Tx-Mgd Small-Cap A |